Yamo Pharmaceuticals

0 followers


Yamo Pharmaceuticals is a clinical-stage pharmaceutical company that develops L1-79, a novel therapy for Autism spectrum disorder.

Industries

Headquarters

Stage

Employees

Links

Org chart

Chuck Bramlage
Chief Executive Officer

Chuck Bramlage

Collapse
No reports!